JANUS HENDERSON GROUP PLC - 31 Oct 2025 SCHEDULE 13G Report for ENANTA PHARMACEUTICALS INC Common Stock (ENTA)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
ENANTA PHARMACEUTICALS INC Common Stock
Symbol
ENTA
Shares outstanding
28,876,595 shares
Disclosed Ownership
3,494,068 shares
Ownership
12%
Form type
SCHEDULE 13G
Filing time
07 Nov 2025, 12:10:28 UTC
Date of event
31 Oct 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 12% 3,494,068 0 3,494,068 Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 11% 2,959,525 0 2,959,525 Kristin Mariani Head of North America Compliance, CCO